Correlation Between IShares Pharmaceuticals and IShares Expanded

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Pharmaceuticals and IShares Expanded at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Pharmaceuticals and IShares Expanded into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Pharmaceuticals ETF and iShares Expanded Tech Software, you can compare the effects of market volatilities on IShares Pharmaceuticals and IShares Expanded and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Pharmaceuticals with a short position of IShares Expanded. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Pharmaceuticals and IShares Expanded.

Diversification Opportunities for IShares Pharmaceuticals and IShares Expanded

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between IShares and IShares is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding iShares Pharmaceuticals ETF and iShares Expanded Tech Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Expanded Tech and IShares Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Pharmaceuticals ETF are associated (or correlated) with IShares Expanded. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Expanded Tech has no effect on the direction of IShares Pharmaceuticals i.e., IShares Pharmaceuticals and IShares Expanded go up and down completely randomly.

Pair Corralation between IShares Pharmaceuticals and IShares Expanded

Considering the 90-day investment horizon IShares Pharmaceuticals is expected to generate 2.4 times less return on investment than IShares Expanded. But when comparing it to its historical volatility, iShares Pharmaceuticals ETF is 1.55 times less risky than IShares Expanded. It trades about 0.07 of its potential returns per unit of risk. iShares Expanded Tech Software is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  6,605  in iShares Expanded Tech Software on September 1, 2024 and sell it today you would earn a total of  3,871  from holding iShares Expanded Tech Software or generate 58.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

iShares Pharmaceuticals ETF  vs.  iShares Expanded Tech Software

 Performance 
       Timeline  
iShares Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Pharmaceuticals ETF has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, IShares Pharmaceuticals is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
iShares Expanded Tech 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Expanded Tech Software are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, IShares Expanded showed solid returns over the last few months and may actually be approaching a breakup point.

IShares Pharmaceuticals and IShares Expanded Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Pharmaceuticals and IShares Expanded

The main advantage of trading using opposite IShares Pharmaceuticals and IShares Expanded positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Pharmaceuticals position performs unexpectedly, IShares Expanded can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Expanded will offset losses from the drop in IShares Expanded's long position.
The idea behind iShares Pharmaceuticals ETF and iShares Expanded Tech Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios